Older people with non small cell lung cancer in clinical stage IIIA and co-morbid conditions: Is curative irradiation feasible? Final results of a prospective study

Lung Cancer

Volumn 37, Issue 2, 2002, Pages 201-206

  Pergolizzi, Stefano ^a,d   Santacaterina, Anna ^a   Renzis, Costantino De ^a   Settineri, Nicola ^b   Gaeta, Michele ^a   Frosina, Pasquale ^a   Russi, Elvio G ^c   Altavilla, Giuseppe ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c S CROCE E CARLE HOSPITAL   (Italy)

^d NONE   (Italy)

Author keywords

Lung; Older; Radiotherapy

Indexed keywords

ADVANCED CANCER; AGE; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; EVALUATION; FEASIBILITY STUDY; FOLLOW UP; HUMAN; HUMAN TISSUE; LUNG FIBROSIS; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION FIELD; RADIATION INJURY; RADIATION PNEUMONIA; SCORING SYSTEM; TISSUE INJURY; TOXICITY; CLINICAL TRIAL; FEMALE; LUNG TUMOR; PHASE 2 CLINICAL TRIAL; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; COMORBIDITY; FEMALE; HUMAN; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; HUMANS;

EID: 0036021972     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(02)00038-7     Document Type: Article

References (30)

1. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
2. Prognostic factors in locoregional non-small cell lung cancer treated with radiotherapy
3. Statistical analysis of survival data
4. Radiation therapy in the management of medically inoperable carcinoma of the lung: Results and implications for future treatment strategies
5. Lung
6. Comorbidity and functional status are independent in older cancer patients
7. Gemcitabine plus vinorelbine in nonsmall cell lung carcinoma patients age 70 years or older or patients who cannot receive cisplatin
8. Radiotherapy of the elderly patient. Radiotherapy tolerance and results in older patients
9. Cancer of the lung. Section 1. Non-small cell lung cancer
10. Adverse influence of younger age on outcome in patients with non-small cell lung carcinoma (NSCLC) treated with radiation therapy (RT) alone
11. Non parametric estimation from incomplete observations
12. Age factor relevant to the development of radiation pneumonitis in radiotherapy of lung cancer
13. Radiotherapy for non-small cell lung cancer in patients aged 75 and over: Safety, effectiveness and possible impact on survival
14. A retrospective quality of life analysis using the lung cancer symptom scale in patients treated with palliative radiotherapy for advanced nonsmall cell lung cancer
15. Clinical and dosimetric predictors of radiation-induced esophageal toxicity
16. The role of multimodality therapy in locoregional non-small cell lung cancer
17. Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma
18. The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): A quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies
19. Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancer
20. Radiotherapy in inoperable stage I lung cancer
21. Retrospective study of radiotherapy for lung cancer in patients aged 75 years and over
22. Age has no impact on acute and late toxicity of curative thoracic radiotherapy
23. Radiotherapy in the elderly
24. Curative radiotherapy (RT) using limited RT treatment fields in elderly patients with non-small cell lung cancer in clinical stage IIIA: A phase II study
25. Radiotherapy alone in elderly patients with medically inoperable stage IIIA and IIIB non-small cell lung cancer
26. Recursive partitioning analysis of radiation therapy oncology group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): Identification of five groups with different survival
27. The aged patient with lung cancer. Management recommendations
28. Curative radiotherapy of early operable non-small cell lung cancer